Hubei Guangji Pharmaceutical Co.,Ltd.’s Net Profit Dropped 59.8% in First Half of 2022

Hubei Guangji Pharmaceutical Co.,Ltd. (湖北广济药业股份有限公司) (000952.SZ) reported a net profit of 23.2 million yuan in the first half of 2022, down 59.8% year-on-year.

Meanwhile, the company posted 376 million yuan in revenue, up 16.3% year-on-year.

At the end of the reporting period, it had 2.2 billion yuan in total assets and 751.9 million yuan in total liabilities, with a liability-to-asset ratio of 34%.